- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 128.54M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $53.21M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $59.69M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.72B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.68B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $944.8M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $977.65M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.65B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.61B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.09B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.02B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.7B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.61B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 123.86M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $16.05M |
| Capex | Q1 2025 · Mar 31, 2024 | $52.52M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$66.69M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.75 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.75 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $48.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | $96.9M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $118.47M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.32B |